Randomized,Open-label and active controlled study of PEG-IFN?-2a in the treatment of chronic hepatitis C in China / 中华传染病杂志
Chinese Journal of Infectious Diseases
;
(12)1997.
Artículo
en Chino
| WPRIM
| ID: wpr-679051
ABSTRACT
Objective To investigate the efficacy, tolerability and safety profiles of PEG IFN alpha 2a(PEG IFN? 2a) in the treatment of chronic hepatitis C in China. Methods 208 patients with chronic hepatitis C were included, and divided into two groups randomly, PEG IFN? 2a group and IFN? 2a Group respectively. There was no significant difference between two groups in pretreatment HCV RNA, HCV genotype and other clinical data. The main parameters to valuate the efficacy were virological response and biochemical response. The side effects were intensively observed. Results Sustained virological response rate in PEG IFN? 2a group was significantly higher than that in IFN? 2a group (41.51% and 16.67% respectively, P
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Chino
Revista:
Chinese Journal of Infectious Diseases
Año:
1997
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS